Larvol Delta - Clinical-Trial-of-BP1001-Liposomal-Grb2-Antisense-Oligonucleotide-in-Combination-With-Dasatinib-in-Patients-With-Ph--CML

prexigebersen (BP1001) - Bio-path

Sprycel (dasatinib) - BMS, Otsuka, Inhibikase

http://clinicaltrials.gov/ct2/show/NCT02923986

Jan 25, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next